Publications by authors named "M I Ruge"

: Vestibular symptoms can severely affect patients with vestibular schwannomas (VSs). Studies assessing vestibular symptoms beyond clinical routine assessment in patients with VS treated by stereotactic radiosurgery (SRS) are scarce. Therefore, we employed the standardized questionnaire Dizziness Handicap Inventory (DHI) to systematically evaluate vestibular symptoms prior to and after SRS.

View Article and Find Full Text PDF

Purpose: Especially in Europe, amino acid PET is increasingly integrated into multidisciplinary neuro-oncological tumor boards (MNTBs) to overcome diagnostic uncertainties such as treatment-related changes. We evaluated the accuracy of MNTB decisions that included the O-(2-[18F]-fluoroethyl)-L-tyrosine (FET) PET information compared with FET PET results alone to differentiate tumor relapse from treatment-related changes.

Patients And Methods: In a single academic center, we retrospectively evaluated 180 MNTB decisions of 151 patients with CNS WHO grade 3 or 4 gliomas (n = 122) or brain metastases (n = 29) presenting equivocal MRI findings following anticancer treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Accurate intraoperative diagnosis of primary CNS lymphoma (PCNSL) is vital for surgical decisions but is challenging due to similar features with other CNS diseases; a new method combines stimulated Raman histology (SRH) with deep learning to improve this process.
  • The RapidLymphoma system uses a portable Raman microscope to create virtual images of tissue samples in under three minutes and employs a deep learning model trained on 54,000 images, allowing it to detect PCNSL and differentiate it from other conditions effectively.
  • In testing, RapidLymphoma achieved a high accuracy rate of 97.81%, performing better than traditional methods, and demonstrated its capability to identify specific histological features crucial for diagnosis, providing quick feedback
View Article and Find Full Text PDF

Background: Following surgery, patients with newly diagnosed glioblastoma frequently enter clinical trials. Nuanced risk assessment is warranted to reduce imbalances between study arms. Here, we aimed (I) to analyze the interactive effects of residual tumor with clinical and molecular factors on outcome and (II) to define a postoperative risk assessment tool.

View Article and Find Full Text PDF
Article Synopsis
  • Accurate intraoperative diagnosis of primary CNS lymphoma (PCNSL) is challenging due to overlapping features with other CNS conditions, but a new method combining stimulated Raman histology (SRH) and deep learning seeks to improve this.
  • The deep learning system, RapidLymphoma, analyzes unprocessed tissue samples quickly, achieving high accuracy in distinguishing PCNSL from other entities, with an overall accuracy of 97.81% in a test cohort.
  • RapidLymphoma not only provides rapid diagnostic results but also visual feedback, aiding surgical decision-making and potential treatment strategies within a critical timeframe.
View Article and Find Full Text PDF